## HCA: HCA Healthcare, Inc. - XLV: Healthcare

### Executive Summary

No thesis match: MRS_10 -4.2% below STRENGTH zone (3.0-6.0%); PEG 1.22 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-3.7% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($462.76)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 7, Bearish: 0)

**1. M&T Bank Corp Acquires 2,238 Shares of HCA Healthcare, Inc. $HCA**
- Source: MarketBeat | 20251205T115743 | Somewhat-Bullish | Relevance: 99%
-  M&T Bank Corp increased its stake in HCA Healthcare Inc. by 20.7% in the second quarter, bringing its total holdings to 13,071 shares valued at $5.008 million. Other institutional investors, such as Norges Bank and Price T Rowe Associates Inc. MD, also made significant adjustments to their HCA Healthcare holdings. The article also provides details on HCA Healthcare's recent earnings, dividend announcement, insider transactions, and analyst ratings, noting an average "Moderate Buy" rating with a consensus price target of $474.53.

**2. HCA Healthcare Announces $4.8 Million Gift to Help Launch Pepperdine Universityâ€™s School of Nursing**
- Source: Yahoo Finance Singapore | 20251205T133227 | Bullish | Relevance: 99%
- HCA Healthcare is donating $4.8 million to Pepperdine University to establish its new School of Nursing, aiming to address the national nursing shortage. This gift will support the development of a 30,000-square-foot facility and provide clinical rotation opportunities for students at HCA Healthcare's Los Robles Regional Medical Center. The School of Nursing, which opened this fall, offers undergraduate and graduate programs and aligns with HCA Healthcare's broader commitment to nursing education and leadership development.

**3. SCS Capital Management LLC Has $26.12 Million Holdings in HCA Healthcare, Inc. $HCA**
- Source: MarketBeat | 20251205T132127 | Bullish | Relevance: 99%
- SCS Capital Management LLC significantly increased its stake in HCA Healthcare (NYSE:HCA) by 137.9% in Q2, now holding 68,180 shares valued at $26.12 million. This comes as HCA beat quarterly earnings and revenue expectations, and analysts have raised price targets, giving the stock a "Moderate Buy" consensus rating with a $474.53 target. Other institutional investors also modified their holdings, while company executives have engaged in stock sales.

**4. 2 Soaring Healthcare Stocks to Buy and Hold for a Decade**
- Source: Finviz | 20251204T120942 | Bullish | Relevance: 99%
- This article highlights HCA Healthcare (NYSE: HCA) and CVS Health (NYSE: CVS) as two healthcare stocks with significant upside potential over the next decade. Both companies have seen impressive stock performance in the past year, and the author argues they are well-positioned for future growth due to strategic initiatives, an aging population, and expanding market reach.

**5. Pepperdine Gets $4.8 Million From HCA Healthcare for New Nursing School**
- Source: MyNewsLA.com | 20251205T204502 | Bullish | Relevance: 98%
-  HCA Healthcare has granted Pepperdine University $4.8 million to support the launch of its new School of Nursing in Calabasas. This initiative aims to address the national nursing shortage, with the school having opened this fall with 68 students and offering various nursing programs. Students will gain practical experience through clinical rotations at HCA Healthcare's Los Robles Regional Medical Center.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-13 | Wells Fargo | $431 | $412 | +5% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-13 | Wells Fargo | main | Equal-Weight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 2 ($3.12M) |
| Sells | 4 ($14.79M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 29.8% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 2 / 7 |

**Top Holders:**
- Vanguard Group Inc: 6.5% (-3.8%)
- Blackrock Inc.: 5.5% (-3.7%)
- Sanders Capital, LLC: 4.7% (-3.9%)
- State Street Corpora: 3.3% (-5.9%)
- JPMORGAN CHASE & CO: 2.6% (+82.2%)

### Key Risks

1. Momentum deterioration: MRS_10 falling (-3.7% 5d) with bearish MACD, trend may be turning.
2. Heavy insider selling: $15M sold (4 transactions in 90 days).
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.22 suggests fair value with growth premium. Forward P/E 16.4x stretched relative to 8% growth. Quality metrics strong (ROE 136%, ROA 12%). Balance sheet: $3.1B free cash flow. Insider selling cluster ($14.8M in 90 days), potential headwind. Institutional flow bullish (2 buying vs 7 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $114.3B |
| Beta | 1.37 |
| 52W Range | $289.98 - $520.00 |
| Short Interest | 2.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.22 |
| Forward P/E | 16.4 |
| Current P/E | 17.6 |
| YoY Growth | 7.7% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from -0.5% to -4.2% (-3.7% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 7.2pp (needs >3.0% for momentum thesis). Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram bearish (-2.56), momentum weakening. RSI neutral at 55.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -4.17% (CS: 12) | Weak |
| RSI_14 | 54.6 | Neutral |
| MACD Histogram | -2.56 | Bearish |
| vs SMA20 | 1.001x | Above |
| vs SMA50 | 1.063x | Above |
| vs SMA200 | 1.255x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $486.70
- **Stop Loss:** $462.76 (4.9% risk)
- **Target:** $510.64 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 20
- **Position Value:** $9,734.00
- **Portfolio %:** 9.73%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate risk appetite persisting. Mixed earnings signals with industrial weakness (John Deere) offset by consumer/tech strength, while institutional flows show selective positioning rather than broad risk-off. Fed meeting in 9 days provides near-term catalyst but current data suggests status quo maintenance.*

### Earnings

**Next:** 2026-01-23 (Est: $7.46)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $5.73 | $6.96 | +21.6% |
| 2025Q2 | $6.32 | $6.84 | +8.2% |
| 2025Q1 | $5.75 | $6.45 | +12.1% |
| 2024Q4 | $6.14 | $6.22 | +1.2% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*